Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 2c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
• Grocery Outlet Holding (GO) PT Raised to $12 at TD Cowen